These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38567643)

  • 1. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
    [No Abstract]   [Full Text] [Related]  

  • 2. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
    Kumar S; Bhale G; Brar BK
    Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
    [No Abstract]   [Full Text] [Related]  

  • 3. Itraconazole-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): a rare occurrence.
    Kalita BJ; Das S; Dutta B
    Int J Dermatol; 2020 Nov; 59(11):e419-e421. PubMed ID: 32767394
    [No Abstract]   [Full Text] [Related]  

  • 4. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
    Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
    J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis induced by itraconazole.
    Park YM; Kim JW; Kim CW
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):794-6. PubMed ID: 9146550
    [No Abstract]   [Full Text] [Related]  

  • 7. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symmetrical drug-related intertriginous and flexural exanthema induced by metronidazole suppository.
    Zhang H; Xie Z
    Contact Dermatitis; 2021 Jun; 84(6):486-488. PubMed ID: 33421140
    [No Abstract]   [Full Text] [Related]  

  • 9. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
    Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
    Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rising trends of symmetrical drug related intertriginous and flexural exanthem due to Itraconazole in patients with superficial dermatophytosis: A case series of 12 patients from eastern part of India.
    Hassanandani T; Panda M; Agarwal A; Das A
    Dermatol Ther; 2020 Nov; 33(6):e13911. PubMed ID: 32594647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
    Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
    Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings.
    Karadag AS; Ozlu E; Akdeniz N; Uzuncakmak TK; Turkoglu Z; Ozkanli S; Zemheri E
    Cutan Ocul Toxicol; 2016; 35(2):157-9. PubMed ID: 26339719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab.
    Yang SY; Lan CC; Hu SC
    Int J Dermatol; 2017 May; 56(5):571-572. PubMed ID: 28217835
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of fixed drug eruption induced by doxycycline, mimicking a symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
    Favrelière S; Hosteing S; Jazeron JF; Allouchery M; Lafay-Chebassier C; Perault-Pochat MC
    Therapie; 2020; 75(5):511-513. PubMed ID: 31761151
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by amoxicillin-clavulanate.
    Dogru M; Ozmen S; Ginis T; Duman H; Bostanci I
    Pediatr Dermatol; 2012; 29(6):770-1. PubMed ID: 22044408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin-induced symmetric drug-related intertriginous and flexural exanthema.
    Tsai YW; Chung WH; Wang CW; Cheng CY
    Contact Dermatitis; 2022 Jan; 86(1):64-66. PubMed ID: 34553784
    [No Abstract]   [Full Text] [Related]  

  • 19. Maculopapular eruption secondary to itraconazole.
    Batinac T; Zamolo G; Troselj-Vukić B; Biljan D; Petranović D; Kujundzić M
    Coll Antropol; 2008 Jun; 32(2):649-51. PubMed ID: 18756926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
    Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
    Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.